Cargando…
Jasmonates induce Arabidopsis bioactivities selectively inhibiting the growth of breast cancer cells through CDC6 and mTOR
Phytochemicals are used often in vitro and in vivo in cancer research. The plant hormones jasmonates (JAs) control the synthesis of specialized metabolites through complex regulatory networks. JAs possess selective cytotoxicity in mixed populations of cancer and normal cells. Here, direct incubation...
Autores principales: | Bömer, Moritz, Pérez‐Salamó, Imma, Florance, Hannah V., Salmon, Deborah, Dudenhoffer, Jan‐Hendrik, Finch, Paul, Cinar, Aycan, Smirnoff, Nicholas, Harvey, Amanda, Devoto, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022592/ https://www.ncbi.nlm.nih.gov/pubmed/33124043 http://dx.doi.org/10.1111/nph.17031 |
Ejemplares similares
-
COI1-dependent jasmonate signalling affects growth, metabolite production and cell wall protein composition in arabidopsis
por: Bömer, Moritz, et al.
Publicado: (2018) -
Jasmonates and Histone deacetylase 6 activate Arabidopsis genome-wide histone acetylation and methylation during the early acute stress response
por: Vincent, Stacey A., et al.
Publicado: (2022) -
mTOR signalling pathway in stem cell bioactivities and angiogenesis potential
por: Lotfimehr, Hamid, et al.
Publicado: (2023) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
GEFT Inhibits Autophagy and Apoptosis in Rhabdomyosarcoma via Activation of the Rac1/Cdc42-mTOR Signaling Pathway
por: Li, Chunsen, et al.
Publicado: (2021)